Basic Information
Genovac is a contract research and manufacturing organization that provides the world's most advanced antibody discovery solutions. Its immunization technology, combined with various single-cell screening technologies (including Berkeley Lights' Beacon), enables successful targeting of the most challenging objectives. Since its establishment in 1999, Genovac has completed over 3,500 projects, delivering antibodies developed into clinical and commercial drugs to customers in North America, Europe, Australia, and Asia. In addition to its headquarters and laboratories in Fargo, North Dakota, Genovac operates another scientific and production facility in Freiberg, Germany.